Biochemical basis for improving chemotherapeutic regimens in liver malignancies.
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001692:Biological Transport; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D004357:Drug Synergism; D006801:Humans; D007700:Kinetics; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D011743:Pyrimidines / Q000378:metabolism; D014529:Uridine / Q000031:analogs & derivatives / Q000378:metabolism; D014544:Uridine Triphosphate / Q000378:metabolism
D000964:Antimetabolites, Antineoplastic; D011743:Pyrimidines; C001943:5-fluorouridine; D014544:Uridine Triphosphate; D014529:Uridine